310 related articles for article (PubMed ID: 12885815)
1. Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.
Dalton VK; Rue M; Silverman LB; Gelber RD; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin M; Tarbell NJ; Sallan SE; Cohen LE
J Clin Oncol; 2003 Aug; 21(15):2953-60. PubMed ID: 12885815
[TBL] [Abstract][Full Text] [Related]
2. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.
Razzouk BI; Rose SR; Hongeng S; Wallace D; Smeltzer MP; Zacher M; Pui CH; Hudson MM
J Clin Oncol; 2007 Apr; 25(10):1183-9. PubMed ID: 17401007
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related changes in body size in Hispanic children with acute lymphoblastic leukemia.
Baillargeon J; Langevin AM; Lewis M; Grady JJ; Thomas PJ; Mullins J; Estrada J; Pitney A; Sacks N; Pollock BH
Cancer; 2005 Apr; 103(8):1725-9. PubMed ID: 15754333
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemia.
Vilela MI; Viana MB
Pediatr Blood Cancer; 2007 Jan; 48(1):86-92. PubMed ID: 16700045
[TBL] [Abstract][Full Text] [Related]
5. Final height and weight of long-term survivors of childhood malignancies.
Müller HL; Klinkhammer-Schalke M; Kühl J
Exp Clin Endocrinol Diabetes; 1998; 106(2):135-9. PubMed ID: 9628245
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity.
Waber DP; Silverman LB; Catania L; Mautz W; Rue M; Gelber RD; Levy DE; Goldwasser MA; Adams H; Dufresne A; Metzger V; Romero I; Tarbell NJ; Dalton VK; Sallan SE
J Clin Oncol; 2004 Jul; 22(13):2701-7. PubMed ID: 15226337
[TBL] [Abstract][Full Text] [Related]
8. Impact on weight and height with the use of HAART in HIV-infected children.
Guillén S; Ramos JT; Resino R; Bellón JM; Muñoz MA
Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398
[TBL] [Abstract][Full Text] [Related]
9. Influence of treatment modalities on body weight in acute lymphoblastic leukemia.
Groot-Loonen JJ; Otten BJ; van't Hof MA; Lippens RJ; Stoelinga GB
Med Pediatr Oncol; 1996 Aug; 27(2):92-7. PubMed ID: 8649326
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation.
Haddy TB; Mosher RB; Nunez SB; Reaman GH
Pediatr Blood Cancer; 2006 Feb; 46(2):258-61. PubMed ID: 16369923
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between body mass index and leptin levels in children treated for acute lymphoblastic leukemia during and after maintenance therapy].
Muszyńska-Rosłan K; Krawczuk-Rybak M; Topczewska M; Sawicka-Zukowska M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):91-5. PubMed ID: 16813712
[TBL] [Abstract][Full Text] [Related]
12. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.
Barredo JC; Devidas M; Lauer SJ; Billett A; Marymont M; Pullen J; Camitta B; Winick N; Carroll W; Ritchey AK
J Clin Oncol; 2006 Jul; 24(19):3142-9. PubMed ID: 16809737
[TBL] [Abstract][Full Text] [Related]
13. Growth and body composition in response to chemotherapy in children with acute lymphoblastic leukemia.
Halton JM; Atkinson SA; Barr RD
Int J Cancer Suppl; 1998; 11():81-4. PubMed ID: 9876486
[TBL] [Abstract][Full Text] [Related]
14. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
[TBL] [Abstract][Full Text] [Related]
15. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
16. Changes in body mass index in long-term survivors of childhood acute lymphoblastic leukemia treated without cranial radiation and with reduced glucocorticoid therapy.
Touyz LM; Cohen J; Neville KA; Wakefield CE; Garnett SP; Mallitt KA; Grech AM; Cohn RJ
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27862918
[TBL] [Abstract][Full Text] [Related]
17. Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation.
Bongers ME; Francken AB; Rouwé C; Kamps WA; Postma A
Pediatr Blood Cancer; 2005 Aug; 45(2):139-43. PubMed ID: 15714445
[TBL] [Abstract][Full Text] [Related]
18. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation.
Sklar CA; Mertens AC; Walter A; Mitchell D; Nesbit ME; O'Leary M; Hutchinson R; Meadows AT; Robison LL
Med Pediatr Oncol; 2000 Aug; 35(2):91-5. PubMed ID: 10918229
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for the development of obesity in children surviving ALL and NHL.
Gofman I; Ducore J
J Pediatr Hematol Oncol; 2009 Feb; 31(2):101-7. PubMed ID: 19194192
[TBL] [Abstract][Full Text] [Related]
20. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
